Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Final Quarter for 2017 MIPS Reimbursement Has Begun

From the College  |  October 19, 2017

The final stage of reporting for the Merit-Based Incentive Payment System (MIPS) began Oct. 2, 2017, if you chose the option to report for 90 consecutive days. The MIPS transition year began Jan. 1, 2017, and runs until Dec. 31, 2017. If you subscribed to the Centers for Medicare & Medicaid Services’ (CMS) email, you…

Filed under:From the CollegePractice Support Tagged with:final reporting stageMIPSRheumatology Clinical Registry (RCR)

Pain Treatments Move Closer to U.S. Market

Michele B. Kaufman, PharmD, BCGP  |  October 18, 2017

Two pain treatments, extended-release injectable suspension triamcinolone acetonide (Zilretta) and meloxicam, have seen movement at the U.S. Food and Drug Administration (FDA). In October, the agency approved Zilretta to treat osteoarthritis (OA) knee pain and accepted a new drug application for meloxicam to treat pain. FDA Approves Zilretta On Oct. 6, the FDA approved extended-release,…

Filed under:AnalgesicsDrug Updates Tagged with:Knee Osteoarthritis (OA)knee painmeloxicamosteoarthritis (OA)PainPain Medicationpost-surgeryZilretta

New Studies Examine Impact of Poverty, Race, Ethnicity in Patients with SLE

Elizabeth Hofheinz, MPH, MEd  |  October 17, 2017

To correctly address a problem, one must have a handle on its nuances—a clear understanding of what is linked and how. And thus far, when it comes to lupus, we haven’t reached the point of understanding those intricacies. Things are heading in the right direction, however, with two new studies that get us much closer…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:DiagnosisDisparitiesimpactincomeinequalityLupuspatient carepovertypregnancyracialResearchRheumatic DiseaserheumatologyrisksocioeconomicStressstudySystemic lupus erythematosus

2017 ACR/ARHP Meeting to Highlight Global Educational Opportunities for Rheumatology Health Professionals

Courtesy of the ARHP Practice Committee  |  October 17, 2017

Efficiently meeting the needs of people with rheumatic disease requires the expertise of a team of health professionals. During their formal education, health professionals acquire the knowledge, skills and attitudes that prepare them to best contribute to a healthcare team. Maintaining and expanding that knowledge happens during continuing education and post-graduate programs, which ensure lifelong…

Filed under:Career DevelopmentEducation & TrainingMeeting Reports Tagged with:2017 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)Arthritis Health Professions AssociationCareer developmentEducationglobalmeeting reportsrheumatologistrheumatology health professionalsTraining

The AHRP Research Committee Enhances Research Knowledge, Skills for Members

Adam P. Goode, DPT, PhD, & Afton L. Hassett, PsyD  |  October 17, 2017

Editor’s note: The new Pillar Talk column is developed by the ARHP Executive Committee in an effort to share information about ongoing activities related to our four pillars: Education, Practice, Research and Advocacy. The ARHP Research Subcommittee is committed to promoting research and enhancing research opportunities for health professionals and researchers working in rheumatology. A…

Filed under:Interprofessional PerspectiveResearch Rheum Tagged with:AC&RACR Strategic PlanAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)collaborationinvestigatorknowledgemembersResearchrheumatology health professionals

Letter: Tips to Improve Osteoporosis Screening Rates

Timothy Harrington, MD  |  October 16, 2017

Osteoporosis Screening The aphorism, “Those who do not learn history are doomed to repeat it,” applies to The Rheumatologist August 2017 article that documents the continued low screening rates for those at high risk for osteoporosis-related fragility fractures, in particular people older than 65 and those who have suffered a fracture already. So here’s a…

Filed under:ConditionsOpinionOsteoarthritis and Bone DisordersSpeak Out Rheum Tagged with:Fracturesnurse coordinatorOsteoporosispatient carePractice Managementrheumatologistrheumatologyriskscreening

The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease

Simon M. Helfgott, MD  |  October 16, 2017

An Unforgettable Story Her name was unforgettable. Not only did we share our given names—Simon and Simone, but her French-Canadian surname was based on this appellation, too. I was the junior resident working on our hospital’s nephrology service when she was admitted for evaluation of progressively worsening kidney disease and an overall failure to thrive….

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:Amyloidosisbraincase reportClinicaldementiaDiagnosismortalityneuronoutcomepatient careplaquerheumatologistrheumatology

MACRA: Tips & Tools for Rheumatology Staff

From the College  |  October 4, 2017

All healthcare professionals who work in rheumatology had to start adapting to a new landscape of reporting and documentation on Jan. 1 of this year when the Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act, or MACRA, began. As the changeover continues, the Sunday ARHP session, Your New Role in the Era of…

Filed under:From the CollegePractice SupportQuality Assurance/Improvement Tagged with:2017 ACR/ARHP Annual MeetingMACRAMedicare Access and Children’s Health Insurance Program (CHIP) Reauthorization ActMIPSreporting and documentation

ACR Pursues Solutions for Flawed MIPS Infusion Regulations & Billing Codes

Mary Beth Nierengarten  |  October 4, 2017

While the latest version of the Republican-sponsored healthcare bill once again falters and its prospects of becoming the new law of the land fade, plenty of advocacy work is continuing on behalf of rheumatologists and rheumatology practices. The ACR, along with multiple partners, has renewed its push for regulatory relief in a number of areas…

Filed under:Legislation & Advocacy Tagged with:evaluation and management codesLocal Coverage Determination (LCD)Part B drug paymentsPart D biosimilarsprior authorizationpush for regulatory reliefQualified Clinical Data Registries (QCDRs)Regulatory Relief Coalition

Efficacy Studied Following Accelerated Drug Approvals

Michele B. Kaufman, PharmD, BCGP  |  October 2, 2017

In recent years, the number of drugs to receive accelerated FDA approval has increased. A new study examined whether these drugs have demonstrated efficacy in post-approval trials…

Filed under:Drug Updates Tagged with:acceleratedFDAFDA approvalU.S. Food and Drug Administration (FDA)

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 125
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences